MFDS Holds Meeting with Pharmaceutical Industry in Response to War Aftermath
MOHW: "Monitoring Production and Inventory of Items with Unstable Supply"

The government is managing the supply of pharmaceuticals and medical devices and cracking down on hoarding to ensure that the aftermath of the Middle East war does not disrupt the medical field.


On the 31st of last month, the Ministry of Health and Welfare held the "1st Inter-Ministerial Inspection Meeting of the Emergency Economic Response and Public Welfare Division in Preparation for the Prolonged Middle East War," chaired by Minister Jeong Eun-kyung, to discuss major initiatives of each ministry. The Public Welfare Division of the Ministry of Health and Welfare is one of the practical response teams within the emergency economic response system, with participation from the Ministry of Employment and Labor, Ministry of Education, Ministry of Gender Equality and Family, and the Ministry of Food and Drug Safety.

On the 31st of last month, the Ministry of Health and Welfare held the "1st Inter-Ministerial Inspection Meeting of the Emergency Economic Response and Public Welfare Division in Preparation for the Prolonged Middle East War," chaired by Minister Jeong Eun-kyung, to discuss major initiatives of each ministry. The Public Welfare Division of the Ministry of Health and Welfare is one of the practical response teams within the emergency economic response system, with participation from the Ministry of Employment and Labor, Ministry of Education, Ministry of Gender Equality and Family, and the Ministry of Food and Drug Safety.

View original image

The Ministry of Food and Drug Safety announced on April 2 that, together with the Ministry of Trade, Industry and Energy and the Ministry of Health and Welfare, it held a field meeting with relevant industries to ensure the stable supply of essential pharmaceuticals such as infusion solutions. Companies including HK inno.N, JW Pharmaceutical, GCMS, Daehan Pharm, and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association attended the meeting.


According to the Ministry of Food and Drug Safety, the government has been in continuous communication with companies and medical sites to ensure the stable supply of essential pharmaceuticals. The government has also taken measures to guarantee the ongoing supply of plastic resin used in the production of pharmaceuticals such as infusion solutions. Previously, the Ministry of Trade, Industry and Energy announced on March 30 that it had taken steps to ensure there would be no disruptions in the supply of packaging materials for infusion solutions over the next three months, and that it is pursuing alternative supply options.


At the meeting, the supply status of companies was reviewed and support measures for continued supply were discussed. The industry, expressing concerns over supply disruptions resulting from the Middle East war, requested ▲priority supply of plastic resin for medical use ▲administrative support such as relaxing mandatory requirements for small-volume packaging of medicines ▲financial support reflecting increased production costs.


In response, the government stated that it would swiftly implement proactive administrative measures, including guidance on the priority supply of resin for healthcare use and easing mandatory small-volume packaging rules. The government also said it would consider providing financial support to offset rising costs, such as those related to naphtha.


Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety, said, "Infusion solutions are fundamental and irreplaceable essential medicines that help sustain and restore patients' lives in the medical field," adding, "The government will do its utmost to ensure the stable supply of essential medicines in the field by working as one team with the relevant ministries."


Meanwhile, on March 31, the Ministry of Health and Welfare met with 11 organizations, including representatives from the pharmaceutical and medical product supply sectors, to review market conditions. Upon hearing opinions that, "While there is no immediate shortage, preparations are needed in case the situation is prolonged," the ministry has been monitoring the market situation.


On the ground, there are reports that disruptions in the supply of petrochemical raw materials such as naphtha due to the war are making it more difficult and expensive to secure medical consumables such as syringes and medicine bottles.



The Ministry of Health and Welfare stated, "We are receiving daily reports from six medical associations, including the Korean Hospital Association, on production rates, inventory, and price trends for items with unstable supply," adding, "We will closely manage the situation and respond promptly to ensure that essential surgeries or treatments are not affected." The ministry further said, "We have requested voluntary regulation of essential supply from pharmaceutical and medical product supply and distribution organizations, and we plan to enforce strict administrative guidance to prevent hoarding or price gouging."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing